Sudarshan Pharma Industries Ltd — Others, 16-05-2025: AGM/EGM

Sudarshan Pharma Industries Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company is convening an Extraordinary General Meeting through video conferencing to seek shareholder approval for increasing its borrowing limits and creation of charges, mortgages, and other encumbrances up to Rs. 2500 Cr to support its growth and capacity expansion plans. It also seeks approval for related party transactions with multiple subsidiaries and group entities, covering routine business dealings up to specified limits ranging from Rs. 10 Cr to Rs. 500 Cr, all conducted on arm’s length basis in the ordinary course. These approvals ensure operational flexibility and strengthen strategic collaborations within the Sudarshan Group.